Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
| Email alert
Add to watchlist
day fda approval tumor for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: 4.72%
H: 0.0%
C: 0.0%
fda opioid approval treatment for spray
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 16.59%
H: 0.65%
C: -10.73%
il-15 anktiva fda agonist approval bladder cancer for
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 3.5%
H: 4.77%
C: 2.39%
lung approval cancer cell treatment for
Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
AMTX | $3.9 0.0% 1M
|
Process Industries
|
| O: -1.3%
H: 2.9%
C: 2.9%
approval review million for funding
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DAWN S | $15.18 -8.77% -9.62% 4.6M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
day fda approval tumor for
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
granted approval cancer treatment for
Chesapeake Utilities Corporation Gains Approval to Establish Energy Efficiency Programs in Delaware
Published: 2024-04-22 (Crawled : 13:00) - prnewswire.com
CPK | News | $106.89 1.16% 0.0% 150K
|
Utilities
|
| O: -0.01%
H: 0.94%
C: 0.88%
energy approval corporation
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
LTRN | News | $5.44 -5.72% -6.07% 96K
|
Health Technology
|
| O: 6.74%
H: 5.26%
C: 0.35%
lung pharma japan approval cancer cell for trial
ContextLogic Announces Stockholder Approval of Transaction with Qoo10
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
WISH | $5.81 -3.01% -3.1% 550K
|
|
| O: 16.65%
H: 5.08%
C: 2.28%
approval
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
SBFM | $0.9263 -23.45% -28.97% 10M
|
Professional, Scientific, and T...
|
| O: -65.59%
H: 4.7%
C: -24.79%
pharma biosimilar health approval for canada
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of Six Montana Branches From HTLF Bank
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
HTLF | $36.01 0.25% 0.25% 200K
|
Finance
|
| O: 0.09%
H: 4.5%
C: 4.47%
GBCI | $37.94 -1.17% 0.0% 610K
|
Finance
|
| O: -0.48%
H: 6.27%
C: 5.78%
FRBA | News | $11.92 -3.25% -3.36% 62K
|
Finance
|
| O: 0.0%
H: 0.0%
C: 0.0%
six approval acquisition for
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
Published: 2024-04-17 (Crawled : 09:00) - globenewswire.com
BCRX | News | $4.22 -3.65% -3.79% 4.4M
|
Health Technology
|
| O: 2.97%
H: 0.0%
C: 0.0%
orladeyo health approval
Elys BMG Group Announces Approval for The Ugly Mug Sportsbook in Washington, DC.
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ELYS | $0.1302 14.4% 2.5K
|
Consumer Services
| Email alert
Add to watchlist
approval group for
Foresight Granted Patent Approval in Japan for All-Weather and Lighting Conditions Vision System
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
FRSX | $1.08 1.89% 1.85% 12K
|
Finance
|
| O: 0.0%
H: 1.74%
C: -0.87%
patent japan granted approval system vision for
Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
first patent granted approval for
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.2 -0.07% 0.0% 19K
|
Health Technology
|
| O: 0.19%
H: 0.28%
C: 0.0%
approval for meeting
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.